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Background
Epstein-Barr virus (EBV) infects almost a large percent of
the world’s adult population. Antibody prevalence rates
reach 95% or higher among elderly individuals. Even in
the pediatric population, Epstein Barr infection is com-
mon. Young children most likely acquire primary EBV
infection from close contact that involves exchange of
oral secretions via shared items such as toys, bottles and
other objects. It may present with mild or no symptoms
or with potentially life-threatening fulminant illness.
Infectious mononucleosis caused by Epstein-Barr virus
(EBV) is usually a benign systemic viral disease and occurs
without sequelae but occasionally, it may be complicated
by a variety of neurologic, hematologic, respiratory and
hepatic complications.
Case reports
We present the cases of three children admitted in the
Pediatric Intensive Care Unit of the National Institute for
Infectious Diseases “Prof. Dr. Matei Balş” with serious
complications associated to Epstein-Barr infection. The
first case described by us is a 6 year-old girl diagnosed
with acute encephalomyelitis, the second case a 2 year-old
girl diagnosed with Guillain-Barré syndrome and the third
case a 3 year-old girl with acquired hemophagocytic
lymphohistiocytosis.
The diagnosis was based on clinical signs, hematological,
biochemical and serological assays, MRI (in children with
neurological conditions) and histological examination (in
the patient with hematological complications). No evidence
for immunodeficiency was detected in these children with
acute infection.
Our patients required intensive care measures, antiviral
therapy, corticosteroids, immunoglobulin therapy, phy-
siotherapy (for neurological complications), blood product
transfusions and immunosuppressive therapy (for hemato-
logic complications).
The evolution was favorable with complete recovery
for all 3 children.
Conclusion
Although Epstein Barr infection often involves asympto-
matic or mild disease, severe complications can occur even
in immunocompetent children, with potentially fatal out-
come. With appropriate therapy a good outcome occurred
in all our patients reported with successful neurological
and hematological recovery.
The biology of Epstein Barr virus, virus-host interaction
and the human immune response to infection are still
genuine challenges for medicine today.
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